Novartis AG (NVS)
98.39
+1.11
(+1.14%)
USD |
NYSE |
Apr 24, 16:00
98.79
+0.40
(+0.41%)
After-Hours: 20:00
Novartis Total Assets (Quarterly): 99.94B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 99.94B |
| September 30, 2023 | 112.70B |
| June 30, 2023 | 110.98B |
| March 31, 2023 | 112.24B |
| December 31, 2022 | 117.45B |
| September 30, 2022 | 118.46B |
| June 30, 2022 | 122.91B |
| March 31, 2022 | 125.22B |
| December 31, 2021 | 131.80B |
| September 30, 2021 | 121.21B |
| June 30, 2021 | 124.02B |
| March 31, 2021 | 121.75B |
| December 31, 2020 | 127.78B |
| September 30, 2020 | 129.68B |
| June 30, 2020 | 123.76B |
| March 31, 2020 | 123.10B |
| December 31, 2019 | 118.37B |
| September 30, 2019 | 115.97B |
| June 30, 2019 | 116.29B |
| March 31, 2019 | 137.95B |
| December 31, 2018 | 145.56B |
| September 30, 2018 | 142.99B |
| June 30, 2018 | 142.06B |
| March 31, 2018 | 135.52B |
| December 31, 2017 | 133.08B |
| Date | Value |
|---|---|
| September 30, 2017 | 134.97B |
| June 30, 2017 | 133.75B |
| March 31, 2017 | 131.99B |
| December 31, 2016 | 130.12B |
| September 30, 2016 | 134.01B |
| June 30, 2016 | 131.44B |
| March 31, 2016 | 132.45B |
| December 31, 2015 | 131.56B |
| September 30, 2015 | 132.93B |
| June 30, 2015 | 135.41B |
| March 31, 2015 | 134.94B |
| December 31, 2014 | 125.39B |
| September 30, 2014 | 125.38B |
| June 30, 2014 | 125.77B |
| March 31, 2014 | 125.33B |
| December 31, 2013 | 126.25B |
| September 30, 2013 | 124.59B |
| June 30, 2013 | 121.07B |
| March 31, 2013 | 121.01B |
| December 31, 2012 | 124.19B |
| September 30, 2012 | 121.22B |
| June 30, 2012 | 118.49B |
| March 31, 2012 | 119.41B |
| December 31, 2011 | 117.50B |
| September 30, 2011 | 121.38B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
99.94B
Minimum
Dec 2023
131.80B
Maximum
Dec 2021
119.66B
Average
121.21B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Sandoz Group AG | -- |
| Roche Holding AG | 107.71B |
| Amgen Inc | 97.15B |
| Incyte Corp | 6.782B |
| MorphoSys AG | 2.240B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.20B |
| Shareholders Equity (Quarterly) | 46.67B |
| Debt to Equity Ratio | 0.5254 |
| Current Ratio | 1.155 |
| Net Debt Paydown Yield | 0.22% |